GlassScriptPhysician profile
Gary Andrew Monteiro
NPI 1356549802
$1,761.12
in general payments reported to CMS, 2019-2025
20 companies · $304 in 2025
The $304 reported for 2025 was more than what 87% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2021: $42.58 · 2022: $136 · 2023: $129 · 2024: $849 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,281.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $228.50 | 2022-2024 | Impella |
| Merck Sharp & Dohme LLC | $215.43 | 2022-2025 | Bridion |
| W. L. Gore & Associates, INC. | $207.41 | 2024 | Gore Cardioform Septal Occluder |
| Heartflow, INC. | $173.77 | 2024 | |
| Atricure, INC. | $135.32 | 2024 | |
| Medtronic Vascular, INC. | $125.00 | 2019 | |
| Getinge USA Sales, LLC | $117.64 | 2019 | |
| Abbott Laboratories | $111.94 | 2025 | Cardiomems |
| Medtronic, INC. | $67.01 | 2024 | Harmony |
| Grifols USA, LLC | $58.24 | 2019-2024 | Thrombate III |
| Mindray Ds USA, INC. | $48.35 | 2024 | Te7 Max, Te X |
| La Jolla Pharmaceutical Company | $47.91 | 2024-2025 | Giapreza |
| Hemosonics LLC | $45.48 | 2025 | Qunatra Qplus System, Quantra Qplus System |
| Edwards Lifesciences Corporation | $42.58 | 2021 | |
| Grifols Shared Services North America, INC. | $31.51 | 2025 | Thrombate III |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eagle Pharmaceuticals, INC. | $28.87 | 2023 | |
| Ge Healthcare | $21.52 | 2025 | |
| Avanos Medical | $20.41 | 2019 | |
| Chiesi USA, INC. | $18.44 | 2019 | |
| Becton, Dickinson and Company | $15.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Monteiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.